Docebo Beats Guidance With 14% Revenue Growth, Raises Profitability Outlook
DCBO has more than doubled off its 52-week low of $14.39.
Summary
Docebo reported Q3 2026 total revenue of $70.3 million, up 14% year over year, and said it exceeded its revenue and profitability guidance. Net income jumped to $9.4 million, or $0.38 per share, from $6.1 million, or $0.21 per share, a year earlier, while Adjusted EBITDA rose to $16.7 million, or 23.7% of revenue, from 20.1%. ARR reached $261.5 million, up 11.0%, and the company flagged that its largest OEM customer now represents just 2.1% of ARR versus 6.2% a year ago, reducing concentration risk. Management guided Q4 total revenue to $71.9-$72.1 million with Adjusted EBITDA of $16.9-$17.1 million, and set full-year 2026 total revenue at $276.7 million with Adjusted EBITDA of $55.8 million. The stock is trading near its 52-week high, so the bar was high; the margin expansion and guidance are the key items to weigh against that valuation.
At the time of this announcement, DCBO was trading at $31.32 on NASDAQ in the Technology sector, with a market capitalization of approximately $758.4M. The 52-week trading range was $14.39 to $31.27. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: BusinessWire.